Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction September 11, 2014
Blood d-serine levels as a predictive biomarker for the rapid antidepressant effects of the NMDA receptor antagonist ketamine September 5, 2014
Ketamine safety and tolerability in clinical trials for treatment-resistant depression September 2, 2014
(R,S)-Ketamine metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine increase the mammalian target of rapamycin function July 1, 2014
Examining the psychological mechanisms of psilocybin-assisted smoking cessation treatment: A pilot study July 1, 2014
Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder June 11, 2014
